Selectivity of TMC207 towards Mycobacterial ATP Synthase Compared with That towards the Eukaryotic Homologue

被引:181
作者
Haagsma, Anna C. [1 ]
Abdillahi-Ibrahim, Rooda [1 ]
Wagner, Marijke J. [1 ]
Krab, Klaas [1 ]
Vergauwen, Karen [2 ]
Guillemont, Jerome [2 ]
Andries, Koen [2 ]
Lill, Holger [1 ]
Koul, Anil [2 ]
Bald, Dirk [1 ]
机构
[1] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Mol Cell Biol, NL-1081 HV Amsterdam, Netherlands
[2] Johnson & Johnson Pharmaceut Res & Dev, Dept Antimicrobial Res, B-2340 Beerse, Belgium
关键词
RAT-LIVER MITOCHONDRIA; OXIDATIVE-PHOSPHORYLATION; SUBMITOCHONDRIAL PARTICLES; TUBERCULOSIS; DIARYLQUINOLINES; HOMEOSTASIS; MECHANISM; TOXICITY; R207910; ENZYME;
D O I
10.1128/AAC.01393-08
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学];
摘要
The diarylquinoline TMC207 kills Mycobacterium tuberculosis by specifically inhibiting ATP synthase. We show here that human mitochondrial ATP synthase (50% inhibitory concentration [IC50] of >200 mu M) displayed more than 20,000-fold lower sensitivity for TMC207 compared to that of mycobacterial ATP synthase (IC50 of 10 nM). Also, oxygen consumption in mouse liver and bovine heart mitochondria showed very low sensitivity for TMC207. These results suggest that TMC207 may not elicit ATP synthesis-related toxicity in mammalian cells. ATP synthase, although highly conserved between prokaryotes and eukaryotes, may still qualify as an attractive antibiotic target.
引用
收藏
页码:1290 / 1292
页数:3
相关论文
共 22 条
[1]
Drug-associated mitochondrial toxicity and its detection [J].
Amacher, DE .
CURRENT MEDICINAL CHEMISTRY, 2005, 12 (16) :1829-1839
[2]
CONSTRUCTION OF A BIOLUMINESCENT MYCOBACTERIUM AND ITS USE FOR ASSAY OF ANTIMYCOBACTERIAL AGENTS [J].
ANDREW, PW ;
ROBERTS, IS .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (09) :2251-2254
[3]
A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis [J].
Andries, K ;
Verhasselt, P ;
Guillemont, J ;
Göhlmann, HWH ;
Neefs, JM ;
Winkler, H ;
Van Gestel, J ;
Timmerman, P ;
Zhu, M ;
Lee, E ;
Williams, P ;
de Chaffoy, D ;
Huitric, E ;
Hoffner, S ;
Cambau, E ;
Truffot-Pernot, C ;
Lounis, N ;
Jarlier, V .
SCIENCE, 2005, 307 (5707) :223-227
[4]
14-3-3 protein is a regulator of the mitochondrial and chloroplast ATP synthase [J].
Bunney, TD ;
van Walraven, HS ;
de Boer, AH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (07) :4249-4254
[5]
Modular kinetic analysis of the adenine nucleotide translocator-mediated effects of palmitoyl-CoA on the oxidative phosphorylation in isolated rat liver mitochondria [J].
Ciapaite, J ;
Van Eikenhorst, G ;
Bakker, SJL ;
Diamant, M ;
Heine, RJ ;
Wagner, MJ ;
Westerhoff, HV ;
Krab, K .
DIABETES, 2005, 54 (04) :944-951
[6]
ATP6 homoplasmic mutations inhibit and destabilize the human F1F0-ATP synthase without preventing enzyme assembly and oligomerization [J].
Cortes-Hernandez, Paulina ;
Vazquez-Memije, Martha E. ;
Garcia, Jose J. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (02) :1051-1058
[7]
A computational model of the inhibition of Mycobacterium tuberculosis ATPase by a new drug candidate R207910 [J].
de Jonge, Marc R. ;
Koymans, Luc H. H. ;
Guillemont, Jerome E. G. ;
Koul, Anil ;
Andries, Koen .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2007, 67 (04) :971-980
[8]
Structural model of the transmembrane Fo rotary sector of H+-transporting ATP synthase derived by solution NMR and intersubunit cross-linking in situ [J].
Fillingame, RH ;
Dmitriev, OY .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2002, 1565 (02) :232-245
[9]
Structure, functioning, and assembly of the ATP synthase in cells from patients with the T8993G mitochondrial DNA mutation -: Comparison with the enzyme in Rho0 cells completely lacking mtDNA [J].
García, JJ ;
Ogilvie, I ;
Robinson, BH ;
Capaldi, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (15) :11075-11081
[10]
In vitro antimycobacterial spectrum of a diarylquinoline ATP synthase inhibitor [J].
Huitric, Emma ;
Verhasselt, Peter ;
Andries, Koen ;
Hoffner, Sven E. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (11) :4202-4204